State of Alaska Department of Revenue’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
32,405
-6,667
-17% -$210K 0.01% 960
2026
Q1
$1.09M Sell
39,072
-413
-1% -$13.5K 0.01% 1028
2025
Q4
$1.48M Buy
39,485
+15,721
+66% +$517K 0.02% 867
2025
Q3
$654K Buy
23,764
+867
+4% +$29.9K 0.01% 1305
2025
Q2
$722K Buy
22,897
+1,724
+8% +$55.5K 0.01% 1210
2025
Q1
$702K Sell
21,173
-543
-3% -$19.5K 0.01% 1206
2024
Q4
$747K Buy
21,716
+4,526
+26% +$156K 0.01% 1218
2024
Q3
$687K Sell
17,190
-1,483
-8% -$52.1K 0.01% 1261
2024
Q2
$563K Sell
18,673
-1,309
-7% -$39.4K 0.01% 1319
2024
Q1
$670K Sell
19,982
-197
-1% -$6.32K 0.01% 1244
2023
Q4
$651K Sell
20,179
-740
-4% -$20.7K 0.01% 1227
2023
Q3
$685K Buy
20,919
+1,189
+6% +$41.3K 0.01% 1168
2023
Q2
$694K Sell
19,730
-580
-3% -$20K 0.01% 1189
2023
Q1
$663K Sell
20,310
-327
-2% -$14.9K 0.01% 1214
2022
Q4
$1.14M Buy
20,637
+157
+0.8% +$8.63K 0.01% 888
2022
Q3
$907K Buy
20,480
+3,060
+18% +$149K 0.01% 973
2022
Q2
$849K Buy
17,420
+1,560
+10% +$70.2K 0.01% 1062
2022
Q1
$771K Sell
15,860
-290
-2% -$11.8K 0.01% 1170
2021
Q4
$688K Buy
+16,150
New +$644K 0.01% 1288

Other funds holding HRMY

State of Alaska Department of Revenue's HRMY Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Harmony Biosciences (HRMY) stake by 17% in Q2 2026, selling an estimated $210K and leaving 32,405 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #960.

State of Alaska Department of Revenue first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.48M in Q4 2025. 182 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • State of Alaska Department of Revenue held 32,405 shares of Harmony Biosciences worth $1.18M as of Q2 2026.
  • State of Alaska Department of Revenue sold 6,667 Harmony Biosciences shares in Q2 2026, an estimated $210K.
  • Harmony Biosciences made up 0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #960 holding.
  • State of Alaska Department of Revenue first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • State of Alaska Department of Revenue's Harmony Biosciences position peaked at $1.48M in Q4 2025.
  • 182 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.